ScholarLens Back to search
2011•Unpublished venueRequires access

NCPA to be "loud voice for community pharmacy" at state and federal levels

Christine Blank

Open publisher page 0 citations

Abstract

Soon after taking the reins at NCPA, Douglas Hoey, RPh, MBA, spoke with Drug Topics' Contributing Editor Christine Blank about his short-term and long-term objectives for NCPA.

About this research paper

What this paper is about

Soon after taking the reins at NCPA, Douglas Hoey, RPh, MBA, spoke with Drug Topics' Contributing Editor Christine Blank about his short-term and long-term objectives for NCPA.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Soon after taking the reins at NCPA, Douglas Hoey, RPh, MBA, spoke with Drug Topics' Contributing Editor Christine Blank about his short-term and long-term objectives for NCPA.

Key concepts: Community practice, Medicine, Pharmacy, Community pharmacy, State (computer science), Pharmacy practice, Multistate Pharmacy Jurisprudence Examination, Clinical pharmacy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
NCPA to be "loud voice for community pharmacy" at state and federal levels — Research Paper | ScholarLens